CLINICAL_TRIALS
trial_result
· 2018-08-06
Clinical Trial Update: An Efficacy and Safety Study of Ivacaftor in Patients With Cystic Fibrosis and Two Splicing Mutations [Phase 3]
Summary
Phase 3 trial evaluating Ivacaftor in cystic fibrosis patients with two splicing mutations has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of South Carolina | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2018-08-06